Vitamin D3 During Pregnancy and Cognitive Performance at 10 Years

jamanetwork.com
June 7, 2026
19 min read
57/100
Summary
High-dose vitamin D3 supplementation during pregnancy has been linked to improved cognitive performance in children at age 10. Vitamin D plays a crucial role in brain development, and its deficiency is common among pregnant women.
Key Takeaways
- High-dose vitamin D3 supplementation during pregnancy is hypothesized to positively affect cognitive performance in children evaluated at age 10 years.
- Prenatal vitamin D deficiency has been linked to neuropsychiatric disorders such as autism spectrum disorder and attention-deficit/hyperactivity disorder.
- Previous studies on prenatal vitamin D supplementation have shown inconsistent results regarding its impact on neurodevelopment and cognitive outcomes in children.
- The Copenhagen Prospective Study on Neuro-Psychiatric Development (COPSYCH) is assessing cognitive and psychopathological outcomes in children from a cohort of 700 mother-child pairs.
Coverage & discussions
Hacker News · jamanetwork.com
Community discussions
Historical count: 5 · 5 saved in sample · Historical sample
Analysis ready
Community Sentiment
Positives
- The study highlights the potential cognitive benefits of high-dose vitamin D3 supplementation during pregnancy, suggesting it may enhance verbal and visual memory in children.
- The use of AI tools for post hoc secondary analysis of studies could significantly streamline research processes, making it easier to derive insights from existing data.
Concerns
- The study's limited sample size and the fact that only one cognitive measure remained significant after correction raise concerns about the validity of the findings.
- Critics argue that the study's design lacks generalizability due to its focus on a specific demographic in Denmark, potentially overlooking variations in vitamin D needs across different populations.
- The association between vitamin D and cognitive performance appears weak, with many measures failing to show significant results, which questions the robustness of the conclusions drawn.
Related Articles

OpenAI acquires startup Orchestra Bioâ to beef up its biotech business
Oct 20, 2026

Alternatives to Animal Testing Are Finally Taking Off
Oct 19, 2026

OpenAI discloses four more rogue incidents
Oct 17, 2026
New Withings Users Must Pay $99/Year for Apple Health Syncing
Oct 15, 2026

The brain may be about to have its Ozempic moment
Aug 26, 2026